Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00002847
What this trial is testing

Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center 14
Early research (Phase 1)UnknownNCT00314925
What this trial is testing

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Who this might be right for
CarcinoidNeuroendocrine
Neotropix 60
Early research (Phase 1)Ended earlyNCT01677390
What this trial is testing

A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Seagen Inc. 4
Very early researchWithdrawnNCT02671552
What this trial is testing

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Who this might be right for
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Ended earlyNCT06114940
What this trial is testing

Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)

Who this might be right for
Renal Cell Carcinoma (RCC)
Jinling Hospital, China 17
Not applicableActive Not RecruitingNCT06195150
What this trial is testing

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaVHL Syndrome
IRCCS San Raffaele 3
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Not applicableEnded earlyNCT01507740
What this trial is testing

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Who this might be right for
Hepatocellular CancerNon-small Cell Lung CancerRenal Cell Cancer+1 more
Medical University Innsbruck 60
Testing effectiveness (Phase 2)Ended earlyNCT01239342
What this trial is testing

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Looking for participantsNCT05873686
What this trial is testing

Clinical Study of NXP900 in Subjects With Advanced Cancers

Who this might be right for
Advanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more
Nuvectis Pharma, Inc. 140
Not applicableLooking for participantsNCT07294859
What this trial is testing

Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy

Who this might be right for
NephrectomyRenal Cell CancerAKI - Acute Kidney Injury
Jinling Hospital, China 285
Not applicableStudy completedNCT01227213
What this trial is testing

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
HypertensionRenal FunctionInsulin Sensitivity+1 more
Radboud University Medical Center 20
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableActive Not RecruitingNCT06126159
What this trial is testing

MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers

Who this might be right for
Kidney Neoplasms
Chang Gung Memorial Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT04150562
What this trial is testing

Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

Who this might be right for
Clear-Cell Renal Carcinoma
National Cancer Institute (NCI) 2
Not applicableWithdrawnNCT01104389
What this trial is testing

Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging

Who this might be right for
Renal Tumors
Intuitive Surgical
Not applicableWithdrawnNCT04961320
What this trial is testing

Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
City of Hope Medical Center
Early research (Phase 1)Active Not RecruitingNCT04522323
What this trial is testing

Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
MedImmune LLC 67
Not applicableStudy completedNCT05579847
What this trial is testing

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

Who this might be right for
Renal Cell Carcinoma Stage IV
H. Lee Moffitt Cancer Center and Research Institute 20
Next Page